Medication Related Osteonecrosis of the Jaws (MRONJ)

Overview

 Presented by Dr. Veronica Barreto and Dr. Assabi Isaac.  Both are Oral Surgeons at St. Lukes OMS

Medication Related Osteonecrosis of the Jaws (MRONJ) is a rare but severe side effect of antiresorptive and/or antiangiogenic medications used to treat a number of ailments including metastatic cancers involving bone, Paget's Disease, and most commonly is used for osteoporosis and off label for osteopenia.  The term MRONJ has replaced the older term Biphosphonate-related Osteonecrosis of the Jaws, as we now know that more than just the bisphosphonate class of drugs have been shown to cause the disease. 

We will review the definition of MRONJ, it's classification system, types of antiresorptive  and antiangiogenic medications known to cause MRONJ, symptoms, and treatment options.  For the hygienist, we will touch on what questions you should be asking your patients and knowing when to refer for further management.  

PRICING:

PDHA Academy Members-$30.00

ADHA/PDHA Members-$40.00

Non Members/ Dentists/Staff-$80.00 

 **FOOD PROVIDED** 

 

Course Contact:

Course Categories: Oral / Dental Health Care & Conditions (Hypersensitivity, Trauma, Halitosis, Xerostomia, Orofacial Pain, Oral Complications to Medicine Use, etc)

Provider Approval: Associated, affiliated, sponsored, approved, accredited, or offered by the (ADHA) American Dental Hygienists' Association,The Pennsylvania academy of Dental Hygiene studies

Educational Type: Live

Educational Method: Lecture

Prerequisites : None

Sponsor(s): None

Conflict of Interest Disclosure: None

All CE Zoom related support: support.cezoom.com